Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Channels (Austin, Tex.)|November 12, 2015
Validation of ion channel targetsAaron C Gerlach, Brett M AntonioPharmaceuticals (Basel, Switzerland)|October 8, 2016
Antiepileptic Drug Discovery and Development: What Have We Learned and Where Are We Going?Aaron C Gerlach, Jeffrey L KrajewskiPflugers Archiv : European Journal of Physiology|January 17, 2004
Activation kinetics of the slow afterhyperpolarization in hippocampal CA1 neuronsAaron C Gerlach, James Maylie, John P AdelmanMolecular Pharmacology|October 7, 2009
Pharmacological removal of human ether-à-go-go-related gene potassium channel inactivation by 3-nitro-N-(4-phenoxyphenyl) benzamide (ICA-105574)Aaron C Gerlach, Sally J Stoehr, Neil A CastleNeuroscience Letters|September 8, 2009
The KCNQ2/3 selective channel opener ICA-27243 binds to a novel voltage-sensor domain siteKaren Padilla, Alan D Wickenden, Aaron C Gerlach, et al.Bioorganic & Medicinal Chemistry Letters|December 7, 2024
Development and characterization of pyridyl carboxamides as potent and highly selective Na<sub>v</sub>1.8 inhibitorsMichael Poslusney, Glen Ernst, Yifang Huang, et al.Epilepsia|November 23, 2019
Personalized medicine: Vinpocetine to reverse effects of GABRB3 mutationSantoshi Billakota, J Michael Andresen, Bryant C Gay, et al.Proceedings of the National Academy of Sciences of the United States of America|November 16, 2018
TRPA1 ankyrin repeat six interacts with a small molecule inhibitor chemotypeWei Chou Tseng, David C Pryde, Katrina E Yoger, et al.The Journal of Biological Chemistry|December 21, 2002
Trafficking of the Ca2+-activated K+ channel, hIK1, is dependent upon a C-terminal leucine zipperColin A Syme, Kirk L Hamilton, Heather M Jones, et al.ACS Medicinal Chemistry Letters|June 20, 2017
Discovery of a Series of Indazole TRPA1 AntagonistsDavid C Pryde, Brian E Marron, Christopher W West, et al.Pageof 2